Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
Therapeutic Solutions International Spin-Off Campbell Neurosciences Demonstrates Efficacy Of Kaihani Score In Prediction Of Gambling Addiction
By PR Newswire
Apr 5, 2021 9:00 AM EDT
PRESS RELEASES
Therapeutic Solutions International Demonstrates Potent And Selective Destruction Of Tumor Blood Vessels By Leveraging Pre-Existing Natural Anti-Xenogeneic Antibodies
By PR Newswire
Mar 29, 2021 9:00 AM EDT
PRESS RELEASES
Therapeutic Solutions International Creates Hybrid Cell Designed To Educate Immune System To Choke Cancer Blood Vessels
By PR Newswire
Mar 23, 2021 9:00 AM EDT
PRESS RELEASES
Therapeutic Solutions International Announces Immunological Mechanism Of Action Of StemVacs-V™ IPSC Derived Cancer Immunotherapeutic
By PR Newswire
Mar 22, 2021 9:00 AM EDT
PRESS RELEASES
Therapeutic Solutions International Announces Novel Cancer-Resistant IPSC-Derived Dendritic Cell Immunotherapy: StemVacs-V™
By PR Newswire
Mar 16, 2021 9:00 AM EDT
PRESS RELEASES
Therapeutic Solutions International Spin-off Campbell Neurosciences Announces Umbilical Cord Derived Monocyte Immunotherapy Candidate For Suicide Prevention
By PR Newswire
Mar 4, 2021 9:00 AM EST
PRESS RELEASES
Therapeutic Solutions International Approved On RangeMe To Sell QuadraMune™ And NanoStilbene™ Along With Other Supplements
By PR Newswire
Mar 3, 2021 9:00 AM EST
PRESS RELEASES
Therapeutic Solutions International Approved By Amazon To Sell Its Highly Regarded Immune Supplement QuadraMune™ Along With Other Brands.
By PR Newswire
Feb 26, 2021 9:00 AM EST
PRESS RELEASES
Therapeutic Solutions International Spin-Off Campbell Neurosciences Demonstrates Preliminary Efficacy Of First Blood-Based Test For Gambling Addiction: Kaihani Score™
By PR Newswire
Feb 25, 2021 9:00 AM EST
PRESS RELEASES
Therapeutic Solutions International Uses StemVacs™ Platform To Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells
By PR Newswire
Feb 22, 2021 9:38 AM EST
PRESS RELEASES
Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev To Its Scientific Advisory Board
By PR Newswire
Feb 16, 2021 9:15 AM EST
PRESS RELEASES
Therapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study For Lung Disease
By PR Newswire
Feb 10, 2021 9:15 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports Preliminary Data Suggesting StemVacs Induces Natural Killer Memory To Cancer
By PR Newswire
Feb 8, 2021 9:15 AM EST
PRESS RELEASES
Therapeutic Solutions International Enters Into Master Sales Agreement With Community Shield LLC
By PR Newswire
Feb 4, 2021 9:15 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports Therapeutic Efficacy Of StemVacs Derived Exosomes In Regression Of Glioma
By PR Newswire
Feb 1, 2021 9:15 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports Regression Of Glioma, Lung Cancer And Colorectal Cancer Using StemVacs In Animal Models
By PR Newswire
Jan 25, 2021 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports Successful Treatment Of Breast Cancer Using StemVacs™ Cellular Immunotherapy
By PR Newswire
Jan 19, 2021 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Announces Positive Early Clinical Data From Ongoing Suicidal Ideation Blood Biomarker Clinical Trial With Spinoff Campbell Neurosciences
By PR Newswire
Jan 13, 2021 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports QuadraMune™ Administration Enhances T Cytotoxic Responses In Mouse Model Of Adaptive Immunity
By PR Newswire
Jan 5, 2021 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Launches Campbell Neurosciences Inc As First Suicide Focused Regenerative Psychiatry Biotechnology Company
By PR Newswire
Dec 31, 2020 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Reports QuadraMune™ Increases T Cell Immunity In Animal Studies
By PR Newswire
Dec 30, 2020 9:30 AM EST
PRESS RELEASES
Therapeutic Solutions International Files Patent On NeuroLeukin™ Personalized Immunotherapy For Opioid Addiction
By PR Newswire
Dec 21, 2020 9:00 AM EST
PRESS RELEASES
Therapeutic Solutions International Signs Letter Of Intent With Premier Adipose Stem Cell Company Synova Life Sciences To File IND For Suicide Prevention
By PR Newswire
Dec 16, 2020 3:10 PM EST
PRESS RELEASES
Therapeutic Solutions International Division Of Campbell Neurosciences Files Patent On QuadraMune™ For Treatment Of Major Depressive Disorder
By PR Newswire
Dec 9, 2020 9:30 AM EST
